Multisystem failure: the story of anti-influenza drugs.
dc.contributor.author | Jefferson, T | en_US |
dc.contributor.author | Doshi, P | en_US |
dc.date.accessioned | 2017-04-07T14:55:32Z | |
dc.date.issued | 2014-04-10 | en_US |
dc.date.submitted | 2016-12-21T13:39:30.537Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/22465 | |
dc.format.extent | g2263 - ? | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BMJ | en_US |
dc.subject | Antiviral Agents | en_US |
dc.subject | Drug and Narcotic Control | en_US |
dc.subject | Evidence-Based Medicine | en_US |
dc.subject | History, 20th Century | en_US |
dc.subject | History, 21st Century | en_US |
dc.subject | Humans | en_US |
dc.subject | Influenza, Human | en_US |
dc.subject | Neuraminidase | en_US |
dc.subject | Oseltamivir | en_US |
dc.subject | Pandemics | en_US |
dc.subject | Policy Making | en_US |
dc.subject | Zanamivir | en_US |
dc.title | Multisystem failure: the story of anti-influenza drugs. | en_US |
dc.type | Article | |
dc.rights.holder | (c) BMJ, 2014 | |
dc.identifier.doi | 10.1136/bmj.g2263 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/24721793 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 348 | en_US |